TrialThe Clinical journal of pain2017

Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.